AusBiotech to Lead Australian Pavilion at BIO with Discounts for Aussies

The highly-popular Australian Pavilion will be back at BIO in Boston this year, showcasing the Australian biotech industry at the world's largest and most influential global life sciences conference.

AusBiotech has negotiated a discounted early-bird rate of up to USD$400 off the Premier Access Pass*, which offers access to the main stage programming, receptions and exhibition with the added benefit of BIO One-on-one partnering opportunities. This offer is open to delegates that register through AusBiotech by 14 March 2023.

The Australian biotechnology community is invited to join the AusBiotech delegation and benefit from the wealth of opportunities that BIO brings.

As the national voice of the Australian biotech community, AusBiotech has led the Australian delegation to BIO and hosted the Pavilion for over ten years. The Pavilion will showcase Australian capabilities and promote the strength of the national life sciences sector, helping attendees to foster global connections.

The annual mission to BIO is closely aligned with AusBiotech's strategic plan, which seeks to facilitate global engagement in strong established markets, including North America and growth markets in Asia. The BIO International Convention attracts 15,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. View the full schedule & programme.

To benefit from the AusBiotech early-bird rate, click here to register by 14 March 2023.

*Earlybird AusBiotech Premier Access Pass rate for BIO (USA) members is USD$2400 (standard early-bird rate is USD$2600), and for non-BIO members is USD$2800 (standard early-bird rate is USD$3200). Registrants will be charged in AUD.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.